Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

NovaSterilis awarded soft tissue processing patent

NovaSterilis Inc., specializing in developing applications for supercritical carbon dioxide, has been granted US Patent 8,034,288 B2. The patent, dated October 11, 2011 entitled “Method and Apparatus for Cleaning of Viable Donor Soft Tissue”, covers a new method for cleaning soft allograft tissue including tendon, fascia, and skin with a supercritical fluid, thus avoiding other harmful chemical solvents that may leave residual chemicals.

4 Jan 2012

Accelrys announces acquisition of VelQuest

Accelrys, Inc., a leading scientific enterprise research and development software and services company, today announced that it has acquired privately-held VelQuest Corporation for $35 million in an all-cash transaction.

3 Jan 2012

FDA notes shortage of ADHD medicines

According to the U.S. Food and Drug Administration (FDA) drugs to treat attention deficit hyperactivity disorder (ADHD) are in such short supply that hundreds of patients complain daily to the agency that they are unable to find a pharmacy with enough pills to fill their prescriptions.

2 Jan 2012

Anytime Fitness to open clubs in the Middle East

Anytime Fitness, the fastest-growing fitness club chain in the world, will soon open its first club in the Middle East. The first of several Anytime Fitness clubs in the State of Qatar opened on January 1, 2012.

2 Jan 2012

HimalayaUSA recalls two batches of Organique by Himalaya Nourishing Night Cream

HimalayaUSA announced today it is conducting a voluntary recall of Organique by Himalaya Nourishing Night Cream with batch #S691001 and batch #S691002 effective immediately.

31 Dec 2011

China's revised Foreign Investment Catalogue 2011 moves healthcare service sectors to 'permitted' category

Concord Medical Services Holdings Limited, operator of the largest network of radiotherapy and diagnostic imaging centers in China, comments on the newly issued Foreign Investment Catalogue 2011 revision which moved healthcare service sectors to "permitted" from "restricted" category.

31 Dec 2011

Faulty PIP breast implant fears deepen

After the scare that some French breast implants may be faulty and may need removal at the government's expense the national health insurance agency will file a criminal complaint. The implants, made by now-defunct French company Poly Implant Prothese (PIP), were pulled from the market last year in countries around Europe and South America amid fears they could rupture and leak silicone into the body.

28 Dec 2011

Delcath receives ISO 13485 Certification for Galway facility

Delcath Systems, Inc. today announced that the Company's Galway, Ireland location has achieved ISO 13485:2003 Certification—an internationally recognized quality standard designed to ensure that medical device manufacturers have the necessary comprehensive quality management systems in place to safely design, develop, manufacture and distribute medical devices in the European Union.

28 Dec 2011

Allergan seeks to reassure surgeons, patients about safety of breast implants

Allergan, Inc. seeks to reassure patients and surgeons around the world utilizing Allergan's breast implant devices that its products are not part of the recent investigation into breast implant devices manufactured by French manufacturer, Poly Implant Prosthese (PIP) by regulatory authorities in Europe.

26 Dec 2011

Veloxis, Athena partner to establish competitive presence for AtorFen in emerging markets

Veloxis Pharmaceuticals and Athena Drug Delivery Solutions Pvt. Ltd. today announced an alliance whereby Athena will obtain exclusive rights in certain emerging market territories to manufacture and, with third parties, develop, register and commercialize Veloxis' AtorFen (Fenofibrate Atorvastatin fixed dose combination).

23 Dec 2011

Momenta, Baxter partner to develop and commercialize biosimilars

Baxter International Inc. and Momenta Pharmaceuticals, Inc. today announced that they have entered into a global collaboration to develop and commercialize follow-on biologic products, also known as biosimilars.

From Baxter International Inc. 23 Dec 2011

Oak Pharmaceuticals acquires three Lundbeck hospital-based injectables

Akorn, Inc., a niche generic pharmaceutical company, today announced that its wholly-owned subsidiary, Oak Pharmaceuticals, has acquired three off-patent, branded, hospital-based injectables from the US subsidiary of H. Lundbeck A/S.

23 Dec 2011

Longer looks: Manufacturing killer flu; The ironies of the individual mandate; When the elderly refuse help

In experiments conducted at the University of Wisconsin in Madison and Erasmus University in Rotterdam, the Netherlands, researchers engineered a strain of H5N1. … The next logical step would be for the researchers to publish studies in major scientific journals, describing the newly created flu, including its genetic makeup.

23 Dec 2011

Tunstall completes acquisition of AMAC

Following the announcement on 22 September 2011, American Medical Alert Corp, a leading provider of remote health monitoring and 24/7 communication services that enhance care, accelerate response times, improve operational effectiveness and deliver sustainable patient services, is pleased to announce today the completion of its acquisition by Tunstall Healthcare Group, a leading telehealth and telecare provider based in the UK.

23 Dec 2011

New silk-based microneedle system for controlled-release drug delivery

Bioengineers at Tufts University School of Engineering have developed a new silk-based microneedle system able to deliver precise amounts of drugs over time and without need for refrigeration. The tiny needles can be fabricated under normal temperature and pressure and from water, so they can be loaded with sensitive biochemical compounds and maintain their activity prior to use. They are also biodegradable and biocompatible.

22 Dec 2011

Actavis enters LOI with QRxPharma to commercialize MoxDuo IR in the U.S.

Actavis Group, the international generic pharmaceuticals company, today announced that its US subsidiary, Actavis Inc, has entered into a binding letter of intent (LOI) with QRxPharma Limited to commercialize MoxDuo IR in the United States.

21 Dec 2011

Ranbaxy signs consent decree with U.S. FDA

Ranbaxy Laboratories Ltd. today announced that it has signed a consent decree with the U.S. Food and Drug Administration.

21 Dec 2011

Amgen and Watson to collaborate on biosimilar anti-cancer drugs

Amgen, the largest standalone biotechnology company, and generic drug firm Watson Pharmaceuticals will collaborate on developing biosimilar drugs for cancer.

20 Dec 2011

Yissum introduces novel technology for manufacturing an anti-malaria drug in tobacco

Combating malaria is one of the eight Millennium Development Goals described in the United Nations Millennium Declaration signed by all UN members at the year 2000. A key intervention to control malaria is prompt and effective treatment with artemisinin-based combination therapies.

19 Dec 2011

EMA CHMP recommends approval for BioMarin's Novato manufacturing facility expansion

BioMarin Pharmaceutical Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval for the company's manufacturing facility expansion in Novato, CA.

19 Dec 2011